medigraphic.com
ISSN 1729-519X (Print)

2013, Number 2

<< Back Next >>

Revista Habanera de Ciencias Médicas 2013; 12 (2)

Antibiotic treatment in community acquired pneumonia

Tirado BJI, Cigales RMJ, Morejón GM

Language: Spanish
References: 24
Page: 203-211
PDF size: 49.08 Kb.


ABSTRACT

Introduction: the Community-Acquired Pneumonia is one of the most frequents infections in our environment, with high mortality in patient of the third age.
Objective: to determine the effectiveness of the antibiotics treatments used in the patients with Community-Acquired Pneumonia.
Methods: Observational, retrospective and descriptive study was conducted in in 208 patients admitted at Internal Medicine service of Manuel Fajardo Hospital, during the first 3 trimesters of 2008. The variables studied were the parameters of CRB-65 score, the patients´s final evolution and the antimicrobial regimen used.
Results: the 88% of patients were more than 65 years old. The global mortality was 39.44%, independently of the antimicrobial regimen used. The mortality in the III and IV groups of CRB-65 was 70.6%.
Conclusions: the effectiveness of the three antimicrobial regimens was similar. The mortality was bigger in the patients of the groups III and IV of the CRB-65.


REFERENCES

  1. Grupo de Estudio de la Neumonía Adquirida en la Comunidad. Área de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR. Normativas para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad. Sociedad española de Neumología y Cirugía torácica. Arch Bronconeumol. 2005; 41(5):272- 89.

  2. Apelastegui A. Validation of a predictive rule for the management of communityacquired pneumonia. European Respiratory Journal 2006; 27(1):151-157.

  3. Yandiola PPE, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, Zalacain R, Menendez R, Torres A. Prospective Comparison of Severity Scores for Predicting Clinically Relevant Outcomes for Patients Hospitalized with Community-Acquired Pneumonia. Chest 2009; 135(6):1572-1579.

  4. Buising K.L. et al. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax. 2006; 61:419-424.

  5. Yan Man S, Lee N, Ip M, Antonio GE, Chau SSL, Mak P, Graham CA, Zhang M, Lui G, Chan PKS, Ahuja AT, Hui DS, Sung JJY, Rainer TH. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax. 2007; 62(4):348-353.

  6. Metlay JP, Fine MJ. Testing strategies en the initial management of patients with community-acquired pneumonia. Ann Intern Med. 2003; 138: 109-18.

  7. Lim WS, Van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international and validation study. Thorax. 2003; 58: 377-82.

  8. Fine MJ, Auble TE, Yealy DM, Haunasa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community acquiried pneumonia. N Engl J Med. 1997; 336:243-50.

  9. Mandell AI, Richard G. Wunderink RG, Anzueto A, John G. Bartlet JG, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases. 2007; 44:S27-72.

  10. Brown RB, Iannini P, Gross P, Kunkel M. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claimsmade database. Chest. 2003; 123:150311.

  11. Marras TK, Nopmaneejumruslers C, Chan CK. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis. Am J Med. 2004; 116:385- 93.

  12. Morejón GM, Salup DRR, Cué BM. Actualización en antimicrobianos sistémicos. 1ra edición. La Habana: Editorial Ciencias Médicas; 2005.

  13. Arnal R, Borderías L, Serón C, Zurutuza A. Etiología de la neumonía adquirida en la comunidad que requiere ingreso hospitalario en un período de 39 meses. Arch Bronconeumol. 2002; 38 Supl 2:57.

  14. Bonilla Rodríguez AB, Gómez Rodriguez MJ, Robles Agudo F. et al. Neumonía en el anciano institucionalizado: criterios de derivación y/o clasificación pronóstica. An. Med. Interna (Madrid). [online]. 2003; 20(11): 08-12 [citado 2007-11-04]. Disponible en: http://scielo.isciii.es/scielo.php?pid=S0212- 71992003001100002&script=sci_arttext&tlng=e

  15. Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis. 2004; 4: 112-24.

  16. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999; 13: 197-205.

  17. Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med.1994; 96:313-20.

  18. Álvarez Salas JL, Serrano R. Neumonía en el anciano. Med Clin (Barc). 2001; 117: 454-456.

  19. Anuario estadístico de Cuba 2006. Disponible en: http://www.infomed.sld.cu/servicios/estadisticas/

  20. Bantar C, Bavestrello L, Curcio D, Jasovich A y Grupo ConsenSur. Neumonía Adquirida en la Comunidad en Adultos: Guía para la Terapia Empírica Inicial Basada en Evidencia Local de un Grupo de Trabajo Sudamericano (ConsenSur). 2002.

  21. Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Sociedad Española de Quimioterapia (SEQ). Sociedad Española de Medicina Interna (SEMI) y Sociedad Española de Medicina de Urgencias y Emergencias (SEMES). Tratamiento antibiótico empírico inicial de la neumonía adquirida en la comunidad en el paciente adulto inmunocompetente. Rev Esp Quimioter. 2003; 16:457-66.

  22. Luna CM, Ramírez J, López H, Mazzei JA, Abreu de Oliveira JC, Pereira J. et al. Grupo de trabajo de la Asociación Latinoamericana del Tórax (ALAT). Recomendaciones ALAT sobre la neumonía adquirida de la comunidad. Arch Bronconeumol. 2001; 37:340-8.

  23. Markowitz JS, Pashko S, Gutterman EM, Linde-Zwrble WT, Newbold R. Índices de mortalidad entre los pacientes hospitalizados con neumonía adquirida en la comunidad: re-examen con los datos de tres estados. (Death rates among patients hospitalized with community acquired pneumonia: a reexamination with date from three states. Am J Publich Health. 1996; 86(8):1152-4.

  24. Gil D. Rodrigo, Undurraga P Álvaro, Saldías P Fernando, Jiménez P Patricio, Barros M Manuel. Estudio multicéntrico de factores pronósticos en adultos hospitalizados por neumonía adquirida en la comunidad. Rev. méd. Chile [revista en la Internet]. 2006 Nov [citado 2013 Mar 25]; 134(11): 1357-1366. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034- 98872006001100002&lng=es




2020     |     www.medigraphic.com